Skip to content
OpenCapital
Get started

Flanigan's Enterprises BDL Concentration Risk %

Concentration Risk % at other companies

Identive logo
IdentiveINVE
10.3%+7.7pp
Heartland Express logo
Heartland ExpressHTLD
32%+6.0pp
Enovix Corporation logo
Enovix CorporationENVX
83%+36.0pp
RF Industries logo
RF IndustriesRFIL
100%0.0pp
Weis Markets logo
Weis MarketsWMK
100%0.0pp
Gyre Therapeutics, Inc. logo
Gyre Therapeutics, Inc.GYRE
93.1%-5.3pp

Other financials

Income statement

See full
Revenue$56.5M+5.9%
Gross profit$48.0M+9.7%
Operating income$4.2M+18.6%
Net income$2.9M+6.9%
EPS (diluted)$1.55+6.9%

Balance sheet

See full
Cash & equivalents$22.8M-0.6%
Total debt$47.2M-3.0%
Total equity$68.8M+7.5%
Total assets$144.8M+1.0%

Cash flow

See full
Operating cash flow$2.1M—
CapEx$881.0K-10.5%
Free cash flow$1.3M—

Valuation

See full
Market cap$83.34M+24.2%
Enterprise value$107.68M+11.3%
P/E14×-1.6×
P/S0.4×+0.1×

Profitability

See full
Gross margin97.3%+0.1pp
Operating margin4.9%+1.4pp
Net margin2.8%+0.8pp
FCF margin4.1%—

Returns & leverage

See full
Return on equity9%+2.5pp
Debt / equity0.7×-0.1×
Current ratio1.8×+0.1×